Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 1—January 2005

Multidrug-Resistant Acinetobacter baumannii

Aharon Abbo*, Shiri Navon-Venezia*, Orly Hammer-Muntz*, Tami Krichali*, Yardena Siegman-Igra*, and Yehuda Carmeli*Comments to Author 
Author affiliations: *Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Main Article

Table 3

Multivariate analysis for risk factors for Acinetobacter baumannii*†

Parameter‡ OR 95% CI p value
Male sex 3.84 1.63–8.99 0.002
Ischemic heart disease 3.35 1.44–7.77 0.005
Mechanical ventilation 6.27 2.27–17.33 <0.001
Penicillin use§ 0.38 0.16–0.90 0.029
Metronidazole use 2.33 0.98–5.83 0.071
Any home antimicrobial drug treatment 4.74 1.31–17.15 0.018

*OR, odds ratio; CI, confidence interval.
†Adjusted for length of hospital stay prior to entry to the study.
‡All parameters had been present before A. baumannii identification.
§Including semisynthetics with or without a β-lactamase inhibitor (never sulbactam).

Main Article

Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.